Company Overview
- Headquarters
- 610 Main Street, Cambridge MA
- Website
- angiex.com
- Phone
- (617) 576-1753
- Employees
- 9
- Founded in
- 2015
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 5417 CompaniesNAICS Code 541 CompaniesNAICS Code 541714 CompaniesNAICS Code 54171 CompaniesNAICS Code 54 Companies
- SIC Code
-
SIC Code 873 CompaniesSIC Code 87 Companies
Financials & Stats
Revenue
$6B
Who is Angiex Inc
Angiex Inc. is a privately held biotechnology startup based in Cambridge, Massachusetts. The company employs 9 people and generates an annual revenue of $6 million. Angiex is focused on developing a novel portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs). These innovative drugs are designed to release therapeutic payloads directly into the nucleus or cytosol of cancer cells, maximizing their effectiveness. The company's mission is to leverage newly discovered biological transport mechanisms to create groundbreaking cancer treatments. Angiex was founded by a team of leading experts in angiogenesis, vascular biology, and oncology, bringing a wealth of experience and knowledge to the development of its groundbreaking therapies. For more information about Angiex Inc. and its innovative cancer treatments, please visit angiex.com.
Company Leadership
Angiex Inc Industry Tags
Companies Similar to Angiex Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Angiex Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 6M | 21 | Mountain View, CA | ||
| 6M | 54 | San Francisco, CA | 2016 | |
| 6M | 4 | Mountain View, CA | 2017 | |
| 6M | 3 | San Diego, CA | ||
| 6M | 6 | 2014 |